Free Speech Challenges to the Inflation Reduction Act

The US spends more per capita than any other country on pharmaceuticals because, unlike most countries, it allows manufacturers to set their own prices for brand-name drugs. Brand-name drug prices at launch, on average, have increased from $2115 per year in 2008 to $180 007 per year in 2021.1 Surveys indicate that many individuals in the US refrain from taking or ration their medications due to financial constraints created by high drug prices.

Read more here.